Equity Capital Markets

Company · CIK 1624422

PHAXIAM Therapeutics S.A.

CIK1624422 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inI0
Business addressFrance
Listedno ticker on SEC record today
First annual or quarterly report2018-04-24

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-259690
ShelfEffective
 2021-09-212024-03-054
333-248953
ShelfEffective
 2020-09-212021-05-055
333-232669
ShelfEffective
 2019-07-162019-07-302
333-220867
IPOFinal prospectus
 2017-10-062017-11-135

Filings

18
FiledFilingRegistrationAccession
2024-03-05EFFECTDeclared effective 333-2596909999999995-24-000602
2021-12-16424B5Shelf takedown 333-2596900001193125-21-359377
2021-09-29EFFECTDeclared effective 333-2596909999999995-21-003704
2021-09-21F-3Shelf registered 333-2596900001193125-21-278075
2021-05-05424B5Shelf takedown 333-2489530001193125-21-151821
2021-05-03424B5Shelf takedown 333-2489530001193125-21-148189
2020-10-09EFFECTDeclared effective 333-2489539999999995-20-002806
2020-10-09424B5Shelf takedown 333-2489530001193125-20-267325
2020-09-21F-3Shelf registered 333-2489530001193125-20-250299
2019-07-30EFFECTDeclared effective 333-2326699999999995-19-001732
2019-07-16F-3Shelf registered 333-2326690001193125-19-194786
2017-11-13424B4Final prospectus 333-2208670001193125-17-339954
2017-11-09EFFECTDeclared effective 333-2208679999999995-17-002944
2017-11-08F-1/AAmendment 333-2208670001193125-17-336970
2017-11-06F-1/AAmendment 333-2208670001193125-17-333981
2017-10-06F-1Registration filed 333-2208670001193125-17-306022
2015-07-27DRSDraft made public 377-010830000950123-15-007736
2015-01-09EFFECTDeclared effective 333-2012799999999995-15-000077

All filings of this company · CSV